Early Events in Protein Folding

蛋白质折叠的早期事件

基本信息

  • 批准号:
    10217148
  • 负责人:
  • 金额:
    $ 35.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-06-01 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The structure-function paradigm is a powerful guiding principle that underlies much of our understanding of biological processes. What is often neglected in this picture, however, is the flexibility of protein structures. This flexibility is necessary for a protein to fold to its native, active structure. Furthermore, protein function requires evolution of this native structure with time. Therefore, the dynamics of the protein structure and associated solvent water provide the critical connection between structure and function. The overall goal of this proposal is to elucidate the functional dynamics of hemagglutinin and M2 proton channel that enable influenza virus infection, a problem with significant public health implications. The mechanisms explored in this work are also relevant to other enveloped viruses, in particular HIV. More generally, membrane fusion and proton transport through proteins are of high fundamental interest and we expect the insight gained in these specific studies will contribute to the understanding of a broad range of related systems. We plan to pursue three specific aims: 1) Determine the mechanism of hemagglutinin mediated membrane fusion. We will test a new model for protein mediated membrane fusion that is based on molecular dynamics simulations of this process. We have developed unique methodology base on a laser induced pH jump to initiate the fusion process, and structure specific spectroscopic methods to characterize the hemagglutinin refolding dynamics that drive membrane fusion. This viral protein serves as an archetype for understanding the general mechanism of membrane fusion as a ubiquitous membrane transport process. 2) Determine the mechanism of fusion pore formation. We will test the hypothesis that the hemagglutinin trans-membrane domain (TMD) and fusion peptide (FP) form an oligomeric complex that opens and stabilizes the fusion pore. 3) Determine the molecular mechanism of actively gated proton transport. This work will on a focus on the influenza M2 proton channel, an important model ion channel. Understanding transport of protons through protein channels is critical to many essential biological processes as well as replication of the influenza virus. These aims are linked intellectually by energy landscape concepts and operationally by the methodology developed in our lab for studying both protein and membrane dynamics. Our unique approach will allow us to identify specific protein motions involved in protein mediated membrane fusion and proton channel activation. We expect this work to provide important new insight into the factors that shape the energy landscape of membrane proteins and the coupled membrane dynamics.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD BRIAN DYER其他文献

RICHARD BRIAN DYER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD BRIAN DYER', 18)}}的其他基金

Equipment Core
装备核心
  • 批准号:
    6893254
  • 财政年份:
    2004
  • 资助金额:
    $ 35.64万
  • 项目类别:
Proton Transfer Dynamics in Heme-Copper Oxidases
血红素铜氧化酶中的质子转移动力学
  • 批准号:
    6893238
  • 财政年份:
    2004
  • 资助金额:
    $ 35.64万
  • 项目类别:
EARLY EVENTS IN PROTEIN FOLDING
蛋白质折叠的早期事件
  • 批准号:
    6386239
  • 财政年份:
    1996
  • 资助金额:
    $ 35.64万
  • 项目类别:
EARLY EVENTS IN PROTEIN FOLDING
蛋白质折叠的早期事件
  • 批准号:
    6180843
  • 财政年份:
    1996
  • 资助金额:
    $ 35.64万
  • 项目类别:
EARLY EVENTS IN PROTEIN FOLDING
蛋白质折叠的早期事件
  • 批准号:
    6519696
  • 财政年份:
    1996
  • 资助金额:
    $ 35.64万
  • 项目类别:
Early Events in Protein Folding
蛋白质折叠的早期事件
  • 批准号:
    9027085
  • 财政年份:
    1996
  • 资助金额:
    $ 35.64万
  • 项目类别:
Early Events in Protein Folding
蛋白质折叠的早期事件
  • 批准号:
    7870678
  • 财政年份:
    1996
  • 资助金额:
    $ 35.64万
  • 项目类别:
Early Events in Protein Folding
蛋白质折叠的早期事件
  • 批准号:
    9115170
  • 财政年份:
    1996
  • 资助金额:
    $ 35.64万
  • 项目类别:
EARLY EVENTS IN PROTEIN FOLDING
蛋白质折叠的早期事件
  • 批准号:
    2193027
  • 财政年份:
    1996
  • 资助金额:
    $ 35.64万
  • 项目类别:
Administrative Supplement: Early Events in Protein Folding
行政补充:蛋白质折叠的早期事件
  • 批准号:
    10387732
  • 财政年份:
    1996
  • 资助金额:
    $ 35.64万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 35.64万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 35.64万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 35.64万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 35.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 35.64万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 35.64万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 35.64万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 35.64万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 35.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 35.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了